Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Tinkoff's Board of Directors approved the valuation of Rosbank

5/29/24 ROSB

Board of Directors of Diasoft recommended that dividends be paid for 3 months 2024

5/29/24 DIAS

Kuchus development technology will be developed by an international consortium

5/29/24 SELG

RusHydro reported for 3 months of 2024 by IFRS

5/29/24 HYDR

Price tags of Fix Price will have QR codes

5/29/24 FIXP

Chizhik chain to grow to more than 5,000 stores by 2026

5/29/24 X5

Rosseti Urals reported for 3 months of 2024 by IFRS

5/29/24 MRKU

Whoosh reported for 3 months of 2024 by RAS

5/29/24 WUSH

Yandex launched API Yandex Maps in Turkey

5/29/24 YDEX

Board of Directors of Novoship recommended that dividends be paid for 2023

5/29/24 NOMP